Related Experiment Video
Updated: Jun 26, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Senolytics and cell senescence: historical and evolutionary perspectives
1Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Ave, Los Angeles, CA 90089, USA.
Abstract:
Senolytics are a new class of anti-aging drugs developed to selectively kill 'senescent' cells that are considered harmful in normal aging. More than 20 drug trials are ongoing with diverse 'senolytic cocktails'. This commentary on recent reviews of senolytics gives a historical context of mammalian cell senescence that enabled these new drugs. While cell senescence is considered harmful to aging tissues, many studies show its essential role in some regenerative and developmental processes for which senolytic drugs may interfere. Longer-term studies of side effects are needed before senolytics are considered for general clinical practice. The wide occurrence of cell senescence in eukaryotes, yeast to fish to humans, and suggests an ancient eukaryotic process that evolved multiple phenotypes.
Insights
Senolytics are drugs targeting senescent cells to combat aging. While promising, their essential roles in regeneration require further study before widespread use.
Area of Science:
- Gerontology
- Cell Biology
- Pharmacology
Background:
- Cell senescence, a state of irreversible growth arrest, is implicated in aging.
- Senolytics are emerging drugs designed to eliminate senescent cells.
- Over 20 senolytic drug trials are currently underway globally.
Purpose of the Study:
- To provide historical context for the development of senolytics.
- To discuss the dual role of cell senescence in aging and regeneration.
- To highlight the need for further research on senolytic drug side effects.
Main Methods:
- Review of recent literature on senolytics and cell senescence.
- Historical analysis of mammalian cell senescence research.
- Discussion of potential implications of senolytic interventions.
Main Results:
- Cell senescence, though linked to aging, plays crucial roles in development and regeneration.
- Senolytic drugs may interfere with beneficial regenerative processes.
- The evolutionary history of cell senescence suggests an ancient eukaryotic origin.
Conclusions:
- Senolytics offer a novel approach to anti-aging therapies by targeting senescent cells.
- The essential functions of senescent cells in regeneration necessitate cautious application of senolytics.
- Long-term safety and efficacy studies are crucial before clinical adoption of senolytics.
Related Concept Videos
Replicative Cell Senescence
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria
PI3K/mTOR/AKT Signaling Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Telomeres and Telomerase

